This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: University of California. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: The Innovative Contributions of Javier Morales
Introduction
Javier Morales is a prominent inventor based in Santa Cruz, CA (US). He has made significant strides in the field of biotechnology, particularly in the development of HIV-1 vaccine immunogens. With a total of 3 patents to his name, Morales is recognized for his innovative approaches to combating viral infections.
Latest Patents
Morales' latest patents include groundbreaking work on polypeptide glycopeptide fragments derived from the V1/V2 and V3 domains of the HIV-1 envelope protein gp120. His first patent focuses on the creation of HIV-1 vaccine immunogens based on glycopeptide scaffolds. These scaffolds contain sequences from the V1/V2/V3 and C3 domains of HIV-1 gp120, which are capable of binding multiple broadly neutralizing antibodies when expressed in mammalian cells that incorporate mannose-5 and mannose-9 glycans. Another significant patent involves the V1/V2 fragments of the HIV-1 envelope glycoprotein. This patent details HIV-1 envelope proteins and fragments that possess both naturally occurring and novel engineered epitopes, which can elicit and are recognized by broadly neutralizing antibodies.
Career Highlights
Javier Morales is affiliated with the University of California, where he continues to advance his research and innovation in the field of virology. His work has contributed to a deeper understanding of HIV-1 and the development of potential vaccines.
Collaborations
Morales has collaborated with notable colleagues such as Phillip Berman and Bin Yu, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Javier Morales stands out as an influential inventor in the biotechnology sector, with a focus on HIV-1 vaccine development. His patents reflect a commitment to innovation and a desire to improve public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
